The below lectures have been confirmed until now at ESSDD-6. The list will be updated soon.
- Abu Serajuddin, St. John’s University, USA
Biophamaceutical Risk Assessment Roadmap (BioRAM): Optimization of Clinical Drug Product Performance - Kiyohiko Sugano, Ritsumeikan University, Japan
Basics of Modeling and Simulation in Biopharmaceutics - Klara Valko, Bio-mimetic chromatography Ltd. UK
Application of Lipophilicity, Protein and Phospholipid Binding Measured by HPLC for Prediction of ADME Properties and Toxicity of Compounds - Alex Avdeef, in-ADME Reserch, USA
Salt Solubility - New Insights from ‘Purposeful Loitering’ - Gaia Colombo, University of Ferrara, Italy
Tuning Technologies for Intranasal Drug Delivery Unravel the Multiplicity of Achievable Therapeutic Targets via the Nose - Tatjana Verbić, University of Belgrade, Serbia
Measurements of Plasma Protein Binding – Variety of Experimental Techniques - Katarina Nikolić, University of Belgrade, Serbia
Computer-aided Design of Multitarget Ligands - Godefridus Peters, VU University Medical Center, The Netherlands
Drug Development in Cancer - Rolf Hilfiker, Solvias AG, Switzerland
The Importance of Choosing Optimal Solid Form of a Drug: Salts, Co-crystals, Polymorphs, Amorphous, Solvates - Christel Bergström, Uppsala University, Sweden
Solubility, Permeability and Formulation Studies in Early Drug Development
